Abstract
Objective
Nitric oxide (NO) inhibits thrombus formation, vascular contraction, and smooth muscle cell proliferation. We investigated whether NO release is enhanced after endothelial NO synthase (eNOS) gene transfer in atherosclerotic human carotid artery ex vivo.
Methods and Results
Western blotting and immunohistochemistry revealed that transduction enhanced eNOS expression; however, neither nitrite production nor NO release measured by porphyrinic microsensor was altered. In contrast, transduction enhanced NO production in non-atherosclerotic rat aorta and human internal mammary artery. In transduced carotid artery, calcium-dependent eNOS activity was minimal and did not differ from control conditions. Vascular tetrahydrobiopterin concentrations did not differ between the experimental groups.Treatment of transduced carotid artery with FAD, FMN, NADPH, L-arginine, and either sepiapterin or tetrahydrobiopterin did not alter NO release. Superoxide formation was similar in transduced carotid artery and control. Treatment of transduced carotid artery with superoxide dismutase (SOD), PEG-SOD, PEG-catalase did not affect NO release.
Conclusions
eNOS transduction in atherosclerotic human carotid artery results in high expression without any measurable activity of the recombinant protein. The defect in the atherosclerotic vessels is neither caused by cofactor deficiency nor enhanced NO breakdown. Since angioplasty is performed in atherosclerotic arteries,eNOS gene therapy is unlikely to provide clinical benefit.
Similar content being viewed by others
References
Alcorn JL, Gao E, Chen Q, Smith ME, Gerard RD, Mendelson CR (1993) Genomic elements involved in transcriptional regulation of the rabbit surfactant protein-A gene. Mol Endocrinol 7: 1072–1085
Barton M, Vos I, Shaw S, Boer P, d'Uscio LV, Gröne HJ, Rabelink TJ, Lattmann T, Moreau P, Luscher TF (2000) Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and glomerulosclerosis. J Am Soc Nephrol 11:835–846
Berendji-Grun D, Kolb-Bachofen V, Kroncke KD (2001) Nitric oxide inhibits endothelial IL-1(beta)-induced ICAM-1 gene expression at the transcriptional level decreasing Sp1 and AP-1 activity. Mol Med 7:748–754
Cannon RO (1998) Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clinical Chemistry 44:1809–1819
Chen AF, Jiang SW, Crotty TB, Tsutsui M, Smith LA, O'Brien T, Katusic ZS (1997) Effects of in vivo adventitial expression of recombinant endothelial nitric oxide synthase gene in cerebral arteries. Proc Natl Acad Sci USA 94:12568–12573
Cooney R, Hynes SO, Duffy AM, Sharif F, O'Brien T (2006) Adenoviral-mediated gene transfer of nitric oxide synthase isoforms and vascular cell proliferation. J Vasc Res 43:462–472
Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP (1992) L-arginine improves endothelium–dependent vasodilation in hypercholesterolemic humans. J Clin Invest 90:1248–1253
d'Uscio LV, Baker TA, Mantilla CB, Smith L, Weiler D, Sieck GC, Katusic ZS (2001) Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21:1017–1022
Förstermann U (2006) Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol Chem 387:1521–1533
Fukushima T, Nixon JC (1980) Analysis of reduced forms of biopterin in biological tissues and fluids. Anal Biochem 102:176–188
Lauer T, Kleinbongard P, Preik M, Rauch BH, Deussen A, Feelisch M, Strauer B, Kelm M (2003) Direct biochemical evidence for eNOS stimulation by bradykinin in the human forearm vasculature. Basic Res Cardiol 98:84–89
Lüscher TF, Vanhoutte PM (1990) The Endothelium: Modulator of Cardiovascular Function. CRC Press, Boca Raton
Meyer P, Champion C, Schlötzer-Schrehardt U, Flammer J, Haefliger IO (1999) Localisation of nitric oxide isoforms in porcine ocular tissues. Current Eye Research 18:375–380
Mittereder N, March KL, Trapnell BC (1996) Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virology 70:7498–7509
Mujynya-Ludunge K,Viswambharan H, Driscoll R, Ming X-F, von Segesser LK, Kappenberger L, Yang Z, Vassalli G (2005) Endothelial nitric oxide synthase gene transfer restores endothelium- dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E-deficient mice. Basic Res Cardiol 100:102–111
Nelson SH, Steinsland OS, Wang Y, Yallampalli C, Dong YL, Sanchez JM (2000) Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy. Circ Res 87:406–411
Oemar BS, Tschudi MR, Godoy N, Brovkovith V, Malinski T, Luscher TF (1998) Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 97:2494–2498
Ohara Y, Peterson TE, Harrison DG (1993) Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91:2546–2551
Ohno T, Gordon D, San H, Pompilij VJ, Imperiale MJ, Nabel GJ, Nabel EG (1994) Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 265:781–784
Rekhter MD, Simari RD, Work CW, Nabel GJ, Nabel EG, Gordon D (1998) Gene transfer into normal and atherosclerotic human blood vessels. Circ Res 82:1243–1252
Ross R (1986) The pathogenesis of atherosclerosis – an update. N Engl J Med 314:488–500
Stroes ESG, Kastelein JJ, Cosentino F, Erkelens W, Wever R, Koomans H, Luscher T, Rabelink T (1997) Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 99:41–46
Tanner FC, Carr DP, Nabel GJ, Nabel EG (1997) Transfection of human endothelial cells. Cardiovasc Res 35:522–528
Tanner FC, Yang Z, Duckers E, Gordon D, Nabel GJ, Nabel EG (1998) Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res 82:396–403
Tanner FC,Meyer P, Greutert H, Champion C, Nabel EG, Luscher TF (2000) Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibiting human vascular smooth muscle cell proliferation. Circulation 101:1982–1989
Tanner FC, Largiadèr T, Greutert H, Yang Z, Luscher TF (2004) Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein. J Thorac Cardiovasc Surg 127:20–26
Tarpey MM, White CR, Suarez E, Richardson G, Radi R, Freeman BA (1999) Chemiluminescent detection of oxidants in vascular tissue. Lucigenin but not coelenterazine enhances superoxide formation. Circ Res 84:1203–1211
Tschudi MR, Barton M, Bersinger NA, Moreau P, Cosentino F, Noll G, Malinski T, Luscher TF (1996) Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest 98:899–905
Varenne O, Pislaru S, Gillijns H, van Pelt N, Gerard RD, Zoldhelyi P, van de Werf F, Collen D, Hanssens SP (1998) Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation 98:919–926
von der Thüsen JH, Fekkes ML, Passier R, von Zonnefeld AJ, Mainfroid V, van Berkel TJC, Biessen EAL (2004) Adenoviral transfer of endothelial nitric oxide synthase attenuates lesion formation in a novel murine model of postangioplasty restenosis. Arterioscler Thromb Vasc Biol 24:357–362
Wever RMF, Luscher TF, Cosentino F, Rabelink T (1998) Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 97:108–112
Yang Z, Simari RD, Tanner FC, Stephan D, Nabel GJ, Nabel EG (1996) Gene transfer approaches to the regulation of vascular cell proliferation. Semin Intervent Cardiol 1:181–184
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tanner, F.C., van der Loo, B., Shaw, S. et al. Inactivity of nitric oxide synthase gene in the atherosclerotic human carotid artery. Basic Res Cardiol 102, 308–317 (2007). https://doi.org/10.1007/s00395-007-0650-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00395-007-0650-7